TP53 and melanoma: In addition, we investigated whether pre‐treatment of melanoma cells with NAC inhibits imiquimod‐induced DNA‐binding activity of the transcription factors AP‐1, ATF‐2, ATF‐3 and p53 as a consequence of the inhibition of ASK1.